dr. fauci: you have to realize that people who are anti- vaccination are not a homogeneous group. a couple principles we use, i am sure nancy has additional comments, is you do not create an adversarial rule. the one thing that we never win is saying, you are wrong. that is the first thing. do not have it be, thinking that they are bad people for doing that. maybe there is a hard-core group of people that you will never convince, but there is a pretty good group of people that if you just give them the information, and debunk the false information in a collegial way, you will win over a substantial portion of them, because there are reasons that are false information upon which their decision is based. you could debunk that. and some people do not get vaccinated for a variety of reasons. that is when you open a dialogue on why that is, and very often you can convince them to actually change their minds. mr. bertuzzi: would you like to comment? >> i am the mother of two teenagers, so not so long

and dr. fauci is also one of the key architects of the presidential emergency plan and then just go celebrating the 15th anniversary thank you for all you have done. [applause] >> so talk about the need for the universal vaccine but the background first and sometimes they don't fully appreciate and without fundamental basic it is a very simple fiber there are some things that are important. and for those viruses that mutate very readily that is no surprise but but just the human virus. and with those other species. and with measles or polio or smallpox. so then you are okay and you are good to go. so those that to be infected with and i was infected with measles as a child so once you get it you got it but not so with influenza. and that changes a little bit. but there are two aspects that is seasonal pandemic. and in the influenza field. and then to that greater or lesser extent he influenza outbreak at unpredictable aspect and of that particular strain and the reason we don't have a pandemic ever

dr. fauci, senator blunt mentioned the ebola end themmic and the -- end demic and the news report this morning that said the first case had been found in an urban area, large city in the democratic republic of congo. and given drc's other challenges, how worried are we that that epidemic is going to get out of control again? >> well, obviously, given our prior experience we are on very high alert. there are some factors that mitigate against their having the same situation as we saw in west africa. but there are also factors that actually might favor that. as you mentioned, the first cases that were reported in the very early may, the first week in may, were in a place that is on a remote area called lake tumba, and it's -- the bad news is that it's very difficult to get help in. the good news is it's very difficult to get anybody out. but what you heard this morning in the report is that there is multiple different zones. bakarro is one zone, another zone is an area that has a city of 1.1 mill

you know, dr. fauci showed some data that there's no reason to keep secret, that we don't have vaccines that are 100% effective. there's different levels of effectiveness, efficacy every year, that's real. the goal, however, the thing that we all aspire to together, is to get to that much higher, 90% plus level. and to be on the same team with the public, i think. >> a very great point. >> any other comments in. >> you have to realize that the people who are anti-vaccination, are not a homogenous group. so a couple of principles that we use and i'm sure nancy has some additional comments. is that first of all, you don't create an adversarial role. the one thing that we never win is saying "you're wrong." that's the first thing. so don't have it be, thinking that they're bad people for doing that. the other thing is there's maybe a hard-core group of people that you'll never convince, but there's a pretty good group of people that if you just give them the information, and the debunk false information in

certainly dr. fauci would say, well, goodness, where were we a year ago in terms of zika and ebola and where are we now when it comes to such things as a vaccine for the flu, a vaccine for hiv and maybe also ways to deal with that anti-microbial resistance problem which have come a long way in the last year. my town hall speech has already gone on too long but i think you get the sense there is a long list of things we could point to in just this last year. in case anybody thinks that's fine but is it really worth the money it's also the greatest return on investment of anything that the government spends money on. $8.38 of return in five years from every dollar that you all allocate to nih because of what happens in terms of its economic impact. >> you do, dr. collins, what you do in my town hall meetings, i'm wrapping up and concluding and then i have another paragraphs as well. >> guilty. >> you have a great story to tell and i appreciate you reminding us of those successes. into u. >> thank you, dr.

next, we have dr. fauci, who diagnosesesearch and prevention and treatment at the national institutes of health. the immune pioneered regulation field. he has made numerous important discoveries rate -- related to infectious diseases. he has been a key advisor of the white house of six president and has testified in congress hundreds of times, voicing strong support for biomedical and other key topics. architectsf the key of the presidential emergency relief, a program that has saved millions of lives in the developing world and has celebrated its anniversary two weeks ago. thank you for all you have done and the floor is yours. [applause] dr. fauci: thank you. it is a real pleasure to be with you this morning. you going to talk with about the need for universal flu i want to give you some background first. people sometimes don't thisciate why we need vaccine. we need to understand some of about the flusics itself. an rna virus that mutates readily, but it is hosted in waterfowl, so when you compare it to me

pyeongchang, -- dr. fauci, i was at this university during the zika crisis where they felt they were coming to a conclusion. availableve something next time? >> we have progressed in our vaccine trial to deploying a meaning trial, relatively advanced, not only asking is it safe but does it induce the type of response that you would predict? i am pleased to support the today we have ongoing a phase 2b puertoin mexico, in rico, in texas, and in florida. betweenheduled to have 24000 and 25,000 people in the and 5000 people in the study. i am confident we will have it fully accrued by 2018. if there is an outbreak we can ife an efficacy signal and it is not we are working closely with the fda if we can get enough data to show that it does of -- does induce the type response that you want and a bridge that to the animal data that is very convincing. we are working with the fda to determine if we can get accelerated approval. you can never anticipate their decision but we are being cooperative. next is the flu vacci

with those additional advances but also the basic science of aging is interesting findings and as dr. fauci would say as with the zika virus and ebola virus where are we now? with the vaccine for hiv and with that anti- microbial existence that is come along way but that town hall speeches on on too long but there is a long list of things we can point to and in case anybody thinks it is the greatest return on investment $8.38 returned in eight cents returned in five years for every dollar that you allocate to nih because of the economic impact. >> and thank you doctor collins the record will stay open for one week and we are in recess. [inaudible conversations] [inaudible conversations] . . . . opponents to the nomination they had a interrogation of terrorists captured after 9/11. here are some of the senate debate before the vote

pyeongchang, -- dr. fauci, i was at this university during the zika crisis where they felt they were coming to a conclusion. availableve something next time? >> we have progressed in our vaccine trial to deploying a meaning trial, relatively advanced, not only asking is it safe but does it induce the type of response that you would predict? i am pleased to support the today we have ongoing a phase 2b puertoin mexico, in rico, in texas, and in florida. betweenheduled to have 24000 and 25,000 people in the and 5000 people in the study. i am confident we will have it fully accrued by 2018. if there is an outbreak we can ife an efficacy signal and it is not we are working closely with the fda if we can get enough data to show that it does of -- does induce the type response that you want and a bridge that to the animal data that is very convincing. we are working with the fda to determine if we can get accelerated approval. you can never anticipate their decision but we are being cooperative. next is the flu vacci

dr. richard hotus and over at the far end somebody you know pretty well who's in his 439th hearing or something like that, dr.ing anthony fauci, who is the director of the national institute of allergy and infectious disease. i just want to say to all of you, chairman blunt, ranking member murray and all the friends of nih here today, thank you. you have gone above and beyond in your support of nih research and the patients for whom it brings healing and hope. and on behalf of all of them, i'm immensely grateful for your consistent support and the words you've just spoken give me a great sense of confidence that we are on a very good and strong are path towards the future. i've spent a lot of time with early stage researchers. show you a few pictures. wherever i go, i set aside time to hear directly from them about their dreams, their ideas and, yes, their concerns. i know you, too, have met many of them both in your home districts and sometimes in your much-appreciated visits to nih. as we move forward with implementing the fiscal year 2018 budget and you begin considering the fy-19 request, it's a good time to think about t